This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. Read More: http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html

1. Transparency Market
Research
G-Protein Coupled Receptors (GPCRs) Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast 2014 - 2022
Global G-Protein Coupled Receptors Market Explores Lucrative
Prospects in North America, Global Market to Exhibit 8.80% CAGR
till 2022
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
125 Page ReportPublished Date
29-May-2015
Buy Now Request Sample
Press Release

2. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
2
Transparency Market Research has recently published a report, which gives insights into the growth drivers, key restraints,
and potential opportunities of the global G-protein coupled receptors (GPCRs) market. The report is titled “G-Protein
Coupled Receptors (GPCRs) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 -
2022” and is available on the company website for sale.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html
GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell
surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to
their significant function in cell communication. More than 30% of the drugs available in the global market target GPCRs
and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein. A
wide range of GPCR assays such as cAMP assays, calcium level detection assays, etc. have been developed over the years
that have helped in drug discovery processes worldwide.
The global GPCRs market has been categorized based on six assay types: calcium level detection assays, GTPγS binding
assays, cGMP assays, reporter gene assays, receptor internalization assays, and cAMP assays. The cAMP assays segment
held the largest share of the market, followed by the calcium level detection assays segment in 2013. Key factors attributed
to the high growth of this segment are increasing demand for cAMP assays in high throughput screening (HTS) and various
other major drug discovery platforms, introduction of advanced cAMP assays and wide applicability of these assays in a
range of therapeutic applications.
In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous
system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary,
orthopedics, etc.). Oncology was the largest segment of the global GPCRs market in 2013. The segment includes several
prime cancer therapeutic areas such as breast cancer, leukemia, lung cancer, cervical cancer, prostate cancer, and/or several
other malignant tumorous outgrowths. High prevalence and increasing incidence of several of these cancers are expected to
drive the growth of the segment in the near future.
REPORT DESCRIPTION

3. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
3
Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest
of the World (RoW). North America dominated the global GPCRs market followed by Europe owing to high geriatric
population and rising obesity-related diseases due to unhealthy lifestyle habits, unhealthy eating habits, excessive alcohol
intake and smoking leading to cardiovascular diseases. The regions also account for high number of research and
development activities for the development of highly effective therapeutic drugs, which would require increased usage of
GPCR assays. Asia Pacific was the third largest market for GPCRs, and is expected to register the fastest CAGR during the
forecast period. Large untapped opportunities, improving health care infrastructure, rising research and development
activities, expansion of large pharmaceutical manufacturers and CROs, and rising geriatric population in the region would
contribute to the growth of the market.
Request A Sample Of This Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=550
Thermo Fisher Scientific, Inc., EMD Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays,
Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation,
Abcam plc, and HD Biosciences Co. Ltd. are the major players operating in the global GPCRs market. Most of these players
constantly innovate and develop technologically advanced and/or improved GPCR assays and assay systems to maintain
their positions in the global market. For instance, Tango GPCR Assay System and GeneBLAzer Validated Functional
Assays from Thermo Fisher Scientific, Inc., ACTOne cAMP Assay from Becton, Dickinson and Company and Cyclic AMP
cell-based assay kits from Cisbio Bioassays, would help in capitalizing on future customer preferences. These market
players also collaborate with other companies as well as various global organizations through long-term agreements to
develop innovative, technologically advanced or improved GPCR assays, assay platforms and systems.
Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/g-protein-coupled-receptors-
market.htm

4. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
4
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global G-Protein Coupled Receptors (GPCRs) Market
2.2 Comparative Analysis: Global GPCRs Market Revenue, by Geography, 2013 & 2022 (Value %)
Chapter 3 Global G-Protein Coupled Receptors (GPCRs) Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising Demand for Advanced/Improved GPCR Assays, Assay Systems and Platforms in Ever Growing Drug
Discovery and ADME Toxicity Studies Worldwide
3.2.2 High Prevalence and Incidence of Cardiovascular, Respiratory, and Reproductive Conditions along with Rising
Occurrence of Cancers and Nervous System Disorders Globally
3.2.3 Increased Government Initiatives and Partnerships/ Collaborations are Likely to Boost Demand for Technologically
Advanced GPCR Assays and Assay Systems Worldwide
3.3 Market Restraints
3.3.1 High Cost Involved in the Maintenance of Cell Lines and Costly Equipment and Instruments could Restrain
Demand for GPCR Assays
3.4 Market Opportunities
3.4.1 Development of Technologically Advanced GPCR Assays, Assay Systems and Assay Platforms
3.5 Porter’s Five Forces Analysis: Global GPCRs Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
TABLE OF CONTENT

5. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
5
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Value Chain Analysis: GPCRs Market
3.7 Market Attractiveness Analysis: Global GPCRs Market, by Geography
3.8 Competitive Landscape
3.8.1 Market Share Analysis, by Key Players: Global GPCRs Market, 2013 (Value %)
Chapter 4 Global G-Protein Coupled Receptors (GPCRs) Market, by Assay Type
4.1 Introduction
4.1.1 Global GPCRs Market Revenue, by Assay Type, 2012 – 2022 (USD Million)
4.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Assay Type, 2013 & 2022 (Value %)
4.2 Calcium Level Detection Assays
4.2.1 Global Calcium Level Detection Assays Market Revenue, 2012 – 2022 (USD Million)
4.3 GTPγS Binding Assays
4.3.1 Global GTPγS Binding Assays Market Revenue, 2012 – 2022 (USD Million)
4.4 cGMP Assays
4.4.1 Global cGMP Assays Market Revenue, 2012 – 2022 (USD Million)
4.5 Reporter Gene Assays
4.5.1 Global Reporter Gene Assays Market Revenue, 2012 – 2022 (USD Million)
4.6 Receptor Internalization Assays
4.6.1 Global Receptor Internalization Assays Market Revenue, 2012 – 2022 (USD Million)
4.7 cAMP Assays
4.7.1 Global cAMP Assays Market Revenue, 2012 – 2022 (USD Million)
Chapter 5 Global G-Protein Coupled Receptors (GPCRs) Market, by Therapeutic Areas
5.1 Introduction
5.1.1 Global GPCRs Market Revenue, by Therapeutic Areas, 2012 – 2022 (USD Million)
5.1.2 Comparative Analysis: Global GPCRs Market Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)
5.2 Cardiovascular System

6. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
6
5.2.1 Global GPCR Assays in Cardiovascular Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.3 Central Nervous System (CNS)
5.3.1 Global GPCR Assays in CNS Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.4 Respiratory System
5.4.1 Global GPCR Assays in Respiratory Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.5 Immune System
5.5.1 Global GPCR Assays in Immune System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.6 Reproductive System
5.6.1 Global GPCR Assays in Reproductive System Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.7 Oncology
5.7.1 Global GPCR Assays in Oncology Therapeutics Market Revenue, 2012 – 2022 (USD Million)
5.8 Other Therapeutic Areas
5.8.1 Global GPCR Assays in Other Therapeutic Areas Market Revenue, 2012 – 2022 (USD Million)
Chapter 6 Global G-Protein Coupled Receptors (GPCRs) Market, by Geography
6.1 Introduction
6.1.1 Global GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
6.2 North America
6.2.1 North America GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
6.2.2 United States
6.2.2.1 United States GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.2.3 Canada
6.2.3.1 Canada GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.3 Europe
6.3.1 Europe GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
6.3.2 The United Kingdom
6.3.2.1 United Kingdom GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.3.3 Germany
6.3.3.1 Germany GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.3.4 France

7. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
7
6.3.4.1 France GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.3.5 Rest of Europe
6.3.5.1 Rest of Europe GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific GPCRs Market Revenue, by Country, 2012 – 2022 (USD Million)
6.4.2 China
6.4.2.1 China GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.4.3 Japan
6.4.3.1 Japan GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.4.4 India
6.4.4.1 India GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.4.5 Rest of Asia Pacific
6.4.5.1 Rest of Asia Pacific GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World GPCRs Market Revenue, by Geography, 2012 – 2022 (USD Million)
6.5.2 Latin America
6.5.2.1 Latin America GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.5.3 Middle East
6.5.3.1 Middle East GPCRs Market Revenue, 2012 – 2022 (USD Million)
6.5.4 Africa
6.5.4.1 Africa GPCRs Market Revenue, 2012 – 2022 (USD Million)
Chapter 7 Recommendations
7.1 Develop Technologically Advanced GPCR Assays, Assay Systems and Platforms to Create Future Growth
Opportunities
7.2 Target Emerging Economies of the World for Higher Benefits
7.3 Collaborate to Strengthen Market Presence
Chapter 8 Company Profiles
8.1 Abcam plc

8. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
8
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent developments
8.3 Cisbio Bioassays
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 DiscoveRx Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 EMD Millipore Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Enzo Life Sciences, Inc.

9. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
9
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 HD Biosciences Co. Ltd.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 PerkinElmer, Inc.
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Promega Corporation
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 QIAGEN
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Sigma-Aldrich Corporation

10. G-Protein Coupled Receptors (GPCRs)
Market
Transparency Market Research
10
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Thermo Fisher Scientific, Inc.
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting
services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals
and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report
provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed
segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
About Us
Contact